Crossmark

Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma

Crossref DOI link: https://doi.org/10.1016/j.abd.2023.09.002

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Asato, Marcel Arakaki http://orcid.org/0000-0002-6050-5292
Moares Neto, Francisco Alves http://orcid.org/0009-0001-7820-8106
Moraes, Marcelo Padovani de Toledo http://orcid.org/0000-0001-7598-7768
Ocanha-Xavier, Juliana Polizel http://orcid.org/0000-0002-1200-3730
Takita, Luiz Carlos http://orcid.org/0000-0002-3047-4587
Marques, Mariangela Esther Alencar http://orcid.org/0000-0001-6947-5627
Xavier-Júnior, José Cândido Caldeira http://orcid.org/0000-0003-0503-419X
Funding

Funding for this research was provided by:

FAPESP (2021/09431-0)
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

Version of Record valid from 2024-02-01
More Information

This article is maintained by: Elsevier

Article Title: Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2023.09.002

Content Type: article

Copyright: © 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below